94 related articles for article (PubMed ID: 22118544)
1. Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA.
Kim D; Kwon S; Ahn CS; Lee Y; Choi SY; Park J; Kwon HY; Kwon HJ
BMB Rep; 2011 Nov; 44(11):758-63. PubMed ID: 22118544
[TBL] [Abstract][Full Text] [Related]
2. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.
Jakob T; Walker PS; Krieg AM; Udey MC; Vogel JC
J Immunol; 1998 Sep; 161(6):3042-9. PubMed ID: 9743369
[TBL] [Abstract][Full Text] [Related]
3. Novel immunostimulatory phosphodiester oligodeoxynucleotides with CpT sequences instead of CpG motifs.
Kim D; Jung J; Lee Y; Kwon HJ
Mol Immunol; 2011 Jul; 48(12-13):1494-504. PubMed ID: 21529949
[TBL] [Abstract][Full Text] [Related]
4. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
5. Activation of Toll-like receptor 9 and production of epitope specific antibody by liposome-encapsulated CpG-DNA.
Kim D; Kwon HJ; Lee Y
BMB Rep; 2011 Sep; 44(9):607-12. PubMed ID: 21944255
[TBL] [Abstract][Full Text] [Related]
6. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
7. Production of antibodies with peptide-CpG-DNA-liposome complex without carriers.
Kim D; Kwon S; Rhee JW; Kim KD; Kim YE; Park CS; Choi MJ; Suh JG; Kim DS; Lee Y; Kwon HJ
BMC Immunol; 2011 May; 12():29. PubMed ID: 21592346
[TBL] [Abstract][Full Text] [Related]
8. An indispensable role of type-1 IFNs for inducing CTL-mediated complete eradication of established tumor tissue by CpG-liposome co-encapsulated with model tumor antigen.
Wakita D; Chamoto K; Zhang Y; Narita Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
Int Immunol; 2006 Mar; 18(3):425-34. PubMed ID: 16415100
[TBL] [Abstract][Full Text] [Related]
9. CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice.
Maletto B; Rópolo A; Morón V; Pistoresi-Palencia MC
J Leukoc Biol; 2002 Sep; 72(3):447-54. PubMed ID: 12223511
[TBL] [Abstract][Full Text] [Related]
10. Efficient peritoneal dissemination treatment obtained by an immunostimulatory phosphorothioate-type CpG DNA/cationic liposome complex in mice.
Kuramoto Y; Kawakami S; Zhou S; Fukuda K; Yamashita F; Hashida M
J Control Release; 2008 Mar; 126(3):274-80. PubMed ID: 18237815
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN.
Vasilakos JP; Smith RM; Gibson SJ; Lindh JM; Pederson LK; Reiter MJ; Smith MH; Tomai MA
Cell Immunol; 2000 Aug; 204(1):64-74. PubMed ID: 11006019
[TBL] [Abstract][Full Text] [Related]
12. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of peritoneal dissemination of tumor cells by single dosing of phosphodiester CpG oligonucleotide/cationic liposome complex.
Kuramoto Y; Nishikawa M; Hyoudou K; Yamashita F; Hashida M
J Control Release; 2006 Oct; 115(2):226-33. PubMed ID: 16996162
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal Antibodies Against the Human Respiratory Syncytial Virus Obtained by Immunization with Epitope Peptides and CpG-DNA-liposome Complex.
Park BK; Choi SH; Kim YE; Park S; Lee Y; Lee KW; Kwon HJ
Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):101-9. PubMed ID: 25897608
[TBL] [Abstract][Full Text] [Related]
15. Structural and immunostimulatory properties of Y-shaped DNA consisting of phosphodiester and phosphorothioate oligodeoxynucleotides.
Matsuoka N; Nishikawa M; Mohri K; Rattanakiat S; Takakura Y
J Control Release; 2010 Dec; 148(3):311-6. PubMed ID: 20887761
[TBL] [Abstract][Full Text] [Related]
16. Double-stranded phosphodiester cytosine-guanine oligodeoxynucleotide complexed with calcium phosphate as a potent vaccine adjuvant for activating cellular and Th1-type humoral immunities.
Hanagata N; Li X; Chen MH; Li J; Hattori S
Int J Nanomedicine; 2018; 13():43-62. PubMed ID: 29317815
[TBL] [Abstract][Full Text] [Related]
17. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
18. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice.
Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y
J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis.
Amaral CC; Garcia IP; Fernandes GF; Almeida SR; Camargo ZP; Souza MC
Scand J Immunol; 2005 Oct; 62(4):325-33. PubMed ID: 16253119
[TBL] [Abstract][Full Text] [Related]
20. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
